Home > Boards > US OTC > Delisted > Ocata Therapeutics Inc. (fka OCAT)

Right. By no means are they undervalued. March

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Diana15 Member Profile
 
Followed By 30
Posts 4,928
Boards Moderated 5
Alias Born 05/06/14
160x600 placeholder
Diana15   Sunday, 08/09/15 12:28:55 PM
Re: fulleroots post# 87269
Post # of 92944 
Right. By no means are they undervalued. March financials show that OCATA has no book value (will be a little improved for June, because of dilution). They are at least 5 years away for a Macular Degeneration product. From a financial point of view, the price should be lower. OCATA is at this price level because of their science, that may or may not get to phase 4 completion. Larger and more powerful companies may develop a better method eventually, and move quicker to develop the method, since they will have the resources and influence( and better management).Just IMO.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences